Target intelligence / Profile preview

Fungal cell wall chitin and beta-glucan polymers (BDG/Chitin)

Target
BDG/Chitin
Molecular classification
Polysaccharide, Structural polymer
01

Overview

The fungal cell wall is a dynamic and essential structure that provides mechanical strength and protects the fungus from osmotic pressure. It is primarily composed of a cross-linked network of polysaccharides, most notably chitin and beta-glucans. Chitin is a polymer of N-acetylglucosamine that provides rigidity, while (1,3)-beta-D-glucan forms the main structural scaffold of the wall. These polymers are critical for fungal viability and are absent in human cells, making them highly specific targets for antifungal drug development (Source: NIH, PMC7150130). Echinocandins, such as caspofungin and micafungin, target the synthesis of beta-glucan by inhibiting the enzyme (1,3)-beta-D-glucan synthase, which leads to cell wall instability and lysis (Source: StatPearls, NBK532273). Chitin synthesis is targeted by compounds like Nikkomycin Z, which acts as a competitive inhibitor of chitin synthase (Source: PubMed, 16461019). Clinically, the presence of (1,3)-beta-D-glucan in the blood serves as a vital biomarker for the early detection of invasive fungal infections (Source: Journal of Clinical Microbiology, 43(9)). Resistance to these treatments often arises through mutations in the FKS genes, which encode the catalytic subunits of the glucan synthase enzyme.

Other names
(1,3)-beta-D-glucanChitinFungal cell wall polysaccharidesBeta-glucan1,3-beta-glucan
02

Mechanism of action

Inhibition of (1,3)-beta-D-glucan synthase and competitive inhibition of chitin synthase

03

Biological functions

Structural integrityOsmotic protectionCell wall morphogenesisImmune modulation
04

Disease associations

InfectionInvasive candidiasisAspergillosisPneumocystis pneumoniaFungal endophthalmitis
05

Safety considerations

FKS gene mutations leading to drug resistanceParadoxical growth effect at high drug concentrationsLimited activity against Cryptococcus and Zygomycetes speciesInfusion-related reactionsPotential for hepatotoxicity with certain echinocandins
06

Interacting drugs

Caspofungin

5 more in the full profile.

07

Biomarkers

(1,3)-beta-D-glucan (BDG) assaySerum BDG levelsFKS1 gene mutationsFKS2 gene mutations

Beyond the preview

Go deeper on Fungal cell wall chitin and beta-glucan polymers (BDG/Chitin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungal cell wall chitin and beta-glucan polymers (BDG/Chitin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call